What is pre-capillary pulmonary hypertension (PH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pre-Capillary Pulmonary Hypertension: Definition and Classification

Pre-capillary pulmonary hypertension (PH) is defined as a mean pulmonary arterial pressure (mPAP) >20 mmHg at rest, with a pulmonary arterial wedge pressure (PAWP) ≤15 mmHg and pulmonary vascular resistance (PVR) ≥3 Wood units, as measured by right heart catheterization. 1, 2

Hemodynamic Parameters

Pre-capillary PH is characterized by specific hemodynamic criteria:

  • mPAP >20 mmHg at rest
  • PAWP ≤15 mmHg (normal left atrial pressure)
  • PVR ≥3 Wood units

These parameters are essential for distinguishing pre-capillary PH from other forms of pulmonary hypertension, particularly post-capillary PH, which has a PAWP >15 mmHg. 1, 2

Clinical Classification

Pre-capillary PH encompasses several clinical groups in the World Health Organization (WHO) classification:

  1. Group 1: Pulmonary Arterial Hypertension (PAH)

    • Idiopathic PAH
    • Heritable PAH (BMPR2, ALK1, EIF2AK4 mutations)
    • Drug and toxin-induced PAH
    • Associated PAH (connective tissue diseases, HIV, portal hypertension, congenital heart disease, schistosomiasis)
  2. Group 3: PH due to lung diseases and/or hypoxia

    • Chronic obstructive pulmonary disease
    • Interstitial lung disease
    • Sleep-disordered breathing
    • Alveolar hypoventilation disorders
    • Chronic exposure to high altitude
    • Developmental lung diseases
  3. Group 4: Chronic thromboembolic PH (CTEPH) and other pulmonary artery obstructions

    • CTEPH
    • Other pulmonary artery obstructions (tumors, arteritis, congenital stenoses, parasites)
  4. Group 5: PH with unclear and/or multifactorial mechanisms

    • Hematological disorders
    • Systemic disorders (sarcoidosis, pulmonary histiocytosis)
    • Metabolic disorders
    • Others (fibrosing mediastinitis, chronic renal failure) 1

Diagnostic Approach

Right heart catheterization is mandatory for the definitive diagnosis of pre-capillary PH, as it provides direct measurement of the key hemodynamic parameters. 2

The diagnostic algorithm includes:

  1. Initial suspicion: Based on symptoms (dyspnea, fatigue, syncope) and risk factors
  2. Non-invasive assessment: Echocardiography showing elevated systolic pulmonary artery pressure
  3. Exclusion of left heart disease: Normal PAWP ≤15 mmHg
  4. Determination of PVR: Value ≥3 Wood units confirms significant pulmonary vascular disease
  5. Etiological workup: To identify the specific cause and classify according to WHO groups

Clinical Significance

The distinction between pre-capillary and post-capillary PH is crucial for:

  • Treatment decisions: Pre-capillary PH may benefit from pulmonary vasodilator therapies, while post-capillary PH requires treatment of the underlying left heart disease 2
  • Prognosis: Different forms of pre-capillary PH have varying prognoses
  • Therapeutic targets: The pathophysiological mechanisms differ between pre-capillary and post-capillary PH

Important Considerations

  • In some cases, a fluid challenge (500 mL saline over 10 minutes) during right heart catheterization may unmask occult left heart disease in patients with borderline PAWP values 2
  • Combined pre- and post-capillary PH can occur when both pulmonary vascular disease and left heart disease are present (mPAP >20 mmHg, PAWP >15 mmHg, PVR ≥3 Wood units) 1
  • The definition of PH has evolved over time, with the threshold for mPAP being lowered from ≥25 mmHg to >20 mmHg in the most recent guidelines 1, 3

Understanding the hemodynamic definition and classification of pre-capillary PH is essential for appropriate diagnosis, risk stratification, and management of affected patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Hypertension Diagnosis and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Definition, classification and diagnosis of pulmonary hypertension.

The European respiratory journal, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.